OneMedPlace Announces Panel Discussions and Workshops for “2010 New York OneMedForum”

OneMedPlace announced today that its “2010 New York OneMedForum” finance conference, which will be held next week — June 29-30, 2010, at New York’s historic Roosevelt Hotel — will include two panel discussions and eight workshops. In addition, 74 private and public companies are scheduled to present from the podium. The goal of the “2010 New York OneMedForum” is to connect private and public (microcap) medtech, biotech and health information companies with a global group of active healthcare investors.

The opening panel discussion on Tuesday, June 29th — Accessing New Sources of Capital — will include: David Gershon, MD, PhD, MPH, Managing Partner, Gershon Capital & Cie (Moderator); Daniel Bertholet, Investment Director, Endeavor Vision; Teo Forcht Dagi, Partner, HLM Venture Partners; Elka Nir, Managing Director, Giza Venture Capital; and Sandra Panem, Managing Partner, Cross Atlantic Ventures.

The following panel discussion and workshops are scheduled for Wednesday, June 30th, the main day of the event:

Panel Discussion — Investment Strategies in a Time of Regulatory Uncertainty and Transformation — Teo Forcht Dagi, HLM Venture Partners (Moderator); Luc Marengere, Vengrowth Partners; Tim Shannon, Canaan Partners; and, Michael King, Wedbush Morgan Securities.

Workshop — Registrations to Approvals, Launch, and After: Navigating the Current Regulatory Whitewaters — Roy J. Sturgeon, Director of FDA Regulatory Affairs and Compliance, Gershon Capital & Cie.

Workshop — Licensing and Intellectual Property — Kevin W. McCabe, Director in the Biotechnology/Chemical Group and in the Litigation Group of Sterne, Kessler, Goldstein & Fox PLLC.

Workshop — Reimbursement — Patty Telgener, Director of Pricing and Reimbursement, Gershon Capital & Cie.

Workshop — Get on BIG Pharma’s Radar — Mark McBride, VP and Managing Director Innovaro Europe, Technology Marketplaces.

Workshop — Health Outcomes and Reimbursement Analysis — Steve Arikian, M.D., Chairman and CEO of Genesis BioPharma Group.

Workshop — Trade Commercialization — Dean Erhardt, Principal, Director of Marketing and Licensing, Gershon Capital & Cie.

Workshop — Capital Formation — Ransom Parker, Tristan Brittain, and Susanne Wilke.

Workshop — Managing Intellectual Property — Dr. Kent Cheng, Ph.D., Co-Director of Patents and Intellectual Property, Gershon Capital & Cie; Martin B. Pavane, Co-Director of Patents and Intellectual property, Gershon Capital & Cie.

Private and public companies scheduled to present at “2010 New York OneMedForum” include: Abviva, Access Pharma, AcuMEMS, Amsterdam Molecular Therapeutics, AMT Bio, Axial Biotech, BioNanomatrix, Biomoda, Biovista, BlackBio, Caleco Pharma, Cardiogenesis, Cequr, Cytochroma, DARA BioSciences, Data Physics Research, DataTrak, Derma Sciences, DermDX, DiFusion Orthopedics, Echo Therapeutics, Edge Therapeutics, Eleison Pharma, EpiCept, Facet Solutions, Flexible Stenting Solutions, Genesis BioPharma, Genomic Expression, Health Integrated, Hilin Life Products, Innova Medical Design, Insite Medical, Intellect Neurosciences, LL Tech, Lucid Technology, MacuClear, Medicasafe, Morris Innovative, Myconostica, NeoMatrix, NeoStem, NewCardio, New World Laboratories, Nuvue, Ovatech, PDS Biotechnology, PearlDiver, PluroGen, Pressure Biosciences, Principio, QuantRX, RecoveryCare, RepRegen™, S.E.A Medical, Silver Bullet Therapeutics, Sound Surgical, Spring Bank Pharmaceuticals, Tagent, TC Software, Transdel Pharma, TriGeminal Solutions, T2 Biosystems, Unity Medical, Urologix, Urovalve, US HIFU, VasoNova, Vaxin, VetCentric, Virtual Medical Centre,, Vyteris,

“2010 New York OneMedForum” Advisory Board Members include: Daniel Bertholet, Endeavor Vision; Darren Black, SV Life Sciences; James Cha, Trevi Ventures; Jonathan Cope, Lincoln Park Financial; Joe Flicek, Amphion Innovations; Teo Forcht Dagi, HLM Venture Partners; Aron Dantzig, Fortress Investment Group; Jordan Davis, Radius Ventures; David Gould, Merlin Nexus; Stacey Feld, Physic Ventures; David Gershon, MD, JD, MPH, Gershon Capital; Charles Lawrence, The Chasson Group; Ira Leiderman, Long Trail Advisors; Michael Liang, Baird Venture Partners; Jeffrey D. Miller, Versum Ventures; Scott Morenstein, Caxton Ventures; Elka Nir, Giza Venture Capital; Peter Nordberg, Nordberg Capital; Sandra Panem, PhD, Cross Atlantic Partners; Corbett Price, Kurron Capital; Christopher Rossman, Conative Capital Management; Salvatore Saraceno, Griffin Securities; Josh Scheinfeld, Lincoln Park Capital; Tim Shannon, Canaan Partners; Eric Sillman, Aperture Venture Partners; Ronald Trahan, Ronald Trahan Associates Inc.; Caleb Winder, Excel Venture Management; Tom Woiwode, Versant Ventures.

For further information about “2010 New York OneMedForum”, contact Cemile (“Gem”) Gokmen at 212-734-1008 or

The comments are closed.